Remember that these medications are just one tool among many for improving health
We now propose a feasible mechanism: Denley and colleagues [119] have beautifully designed a study where they demonstrate how IR has a splice variant lacking exon 11 which confers the receptor affinity for IGF-1 and IGF-2
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) are approved for type 2 diabetes and obesity, not Hashimoto's thyroiditis
This physiological effect, while not necessarily harmful, may contribute to the sensation of heart palpitations reported by some patients
Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population
But for people who want to optimize their natural GLP-1 production while exploring other options, increasing soluble fiber intake is a free, safe, and evidence-supported strategy